NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

XOMA Corporation (NASDAQ: XOMAO)

 
XOMAO Technical Analysis
4
As on 25th Jun 2025 XOMAO STOCK Price closed @ 25.34 and we RECOMMEND Buy for LONG-TERM with Stoploss of 25.15 & Strong Buy for SHORT-TERM with Stoploss of 24.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

XOMAOSTOCK Price

Open 25.33 Change Price %
High 25.34 1 Day -0.03 -0.12
Low 25.33 1 Week 0.00 0.00
Close 25.34 1 Month 0.30 1.20
Volume 538 1 Year 0.16 0.64
52 Week High 25.83 | 52 Week Low 23.74
 
NASDAQ USA Most Active Stocks
PSTV 0.32 68.42%
AMRS 0.14 100.00%
GNLN 0.01 0.00%
NVDA 154.31 4.33%
HCTI 0.03 0.00%
VOR 0.55 71.88%
LMDX 0.02 0.00%
TSLA 327.55 -3.79%
LCID 2.14 -1.38%
AKTS 0.04 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
CFFEW 0.11 120.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
TBIO 0.05 -80.00%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
SRAX 0.01 -66.67%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
 
 
XOMAO
Daily Charts
XOMAO
Intraday Charts
Whats New @
Bazaartrend
XOMAO
Free Analysis
 
XOMAO Important Levels Intraday
RESISTANCE25.36
RESISTANCE25.35
RESISTANCE25.35
RESISTANCE25.35
SUPPORT25.33
SUPPORT25.33
SUPPORT25.33
SUPPORT25.32
 
XOMAO Forecast June 2025
4th UP Forecast26.82
3rd UP Forecast26.35
2nd UP Forecast26.05
1st UP Forecast25.76
1st DOWN Forecast24.92
2nd DOWN Forecast24.63
3rd DOWN Forecast24.33
4th DOWN Forecast23.86
 
XOMAO Weekly Forecast
4th UP Forecast26.63
3rd UP Forecast26.22
2nd UP Forecast25.96
1st UP Forecast25.71
1st DOWN Forecast24.97
2nd DOWN Forecast24.72
3rd DOWN Forecast24.46
4th DOWN Forecast24.05
 
XOMAO Forecast2025
4th UP Forecast30.25
3rd UP Forecast28.68
2nd UP Forecast27.7
1st UP Forecast26.73
1st DOWN Forecast23.95
2nd DOWN Forecast22.98
3rd DOWN Forecast22
4th DOWN Forecast20.43
 
 
XOMAO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
XOMAO Address
XOMAO
 
XOMAO Latest News
 
Your Comments and Response on XOMA Corporation
 
XOMAO Business Profile
XOMA Corporation, a biotechnology royalty aggregator, engages in helping biotech companies for improving human health. The company acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. It acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance internal drug candidate or for general corporate purposes. The company has a portfolio with approximately 70 assets. It has a pipeline of monoclonal antibodies and technologies available to license to pharmaceutical and biotechnology companies to further clinical development include PTH1R program, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy; XMetA, an insulin receptor-activating antibody to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; and X213, an allosteric inhibitor of prolactin action. The company also licenses antibody discovery, optimization, and development technologies. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Address: 2200 Powell Street, Emeryville, CA, United States, 94608
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service